KalVista Pharmaceuticals
Why Robinhood?
You can watch KALV and buy or sell other stocks, ETFs, and their options commission-free!About KALV
KalVista Pharmaceuticals, Inc. is a clinical stage pharmaceutical company, which engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. Its product candidates are inhibitors of plasma kallikrein being developed for two indications: Sebetralstat for HAE and Factor XIIa.
KALV Key Statistics
Stock Snapshot
KalVista Pharmaceuticals(KALV) stock is priced at $27.00, giving the company a market capitalization of 1.38B. It carries a P/E multiple of -6.75.
On 2026-07-02, KalVista Pharmaceuticals(KALV) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for KalVista Pharmaceuticals(KALV) stock has reached 0, versus its average volume of 951.76K.
Over the past 52 weeks, KalVista Pharmaceuticals(KALV) stock has traded between a high of $27.00 and a low of $9.83.
Over the past 52 weeks, KalVista Pharmaceuticals(KALV) stock has traded between a high of $27.00 and a low of $9.83.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.